Company: PGEN
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001356090-25-000034
Chunk: 22

Company: PRECIGEN, INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 22
---
Item 1. Condensed Consolidated Financial Statements

 Precigen, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

(Amounts in thousands, except share data)September 30,2025December 31,2024AssetsCurrent assetsCash and cash equivalents$14,322 $29,517 Short-term investments106,813 68,393 ReceivablesTrade, less allowance for credit losses of $0 as of both September 30, 2025 and December 31, 2024580 926 Other520 237 Inventory3,059 — Prepaid expenses 4,303 3,341 Total current assets129,597 102,414 Long-term investments2,508 — Property, plant and equipment, net14,813 13,831 Intangible assets, net3,500 4,455 Goodwill15,232 19,139 Right-of-use assets4,861 5,056 Other assets753 371 Total assets$171,264 $145,266 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Table of Contents

Precigen, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited) 

(Amounts in thousands, except share data)September 30,2025December 31,2024Liabilities, Mezzanine Equity and Shareholders' EquityCurrent liabilitiesAccounts payable$6,262 $3,531 Accrued compensation and benefits10,167 8,417 Other accrued liabilities10,824 4,812 Indemnification accruals3,213 3,213 Deferred revenue480 589 Current portion of lease liabilities1,123 956 Total current liabilities32,069 21,518 Long-term debt92,890 — Deferred revenue, net of current portion95 1,934 Lease liabilities, net of current portion4,179 4,546 Warrant liabilities— 50,537 Other long-term liabilities163 — Total liabilities129,396 78,535 Commitments and contingencies (Note 14)Mezzanine equitySeries A Preferred Stock, no par value, 81,000 shares authorized as of September 30, 2025 and December 31, 2024; zero and 79,000 shares issued